Coya Therapeutics, Inc. (COYA)

Coya Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) -10.77M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About COYA

Coya Therapeutics is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (“Tregs”). Tregs and their transcription factors have been shown to be essential to maintaining cellular homeostasis by regulating autoimmune and inflammatory responses and maintaining self-tolerance in mammals. Self-tolerance is the ability of the immune system to recognize self-produced substances as a non-threat while appropriately mounting a response to foreign substances. Dysfunctiona... [Read more]

Industry Health Care
Founded 2020
CEO Howard Berman
Employees 6
Stock Exchange NASDAQ
Ticker Symbol COYA
Full Company Profile

Financial Performance

Financial Statements


Coya Therapeutics IPO Registration Document (S-1)

Coya Therapeutics has filed to go public with an IPO on the NASDAQ.

1 week ago - SEC